Table 2

Patient characteristics

ICEA-ICEP
n 40 43 NA 
Age, mean y (range) 67.9 (60.2-84.5) 67.6 (60.6-76.8) .78 
Sex, no. M/F 24/16 21/22 .38 
Leukocytes, no. patients (mean ×106/mL) 39 (33.9) 41 (50.1) .12 
LDH, no. patients (mean U/L) 39 (620) 39 (564) .66 
Type of AML, no. patients   .03 
    De novo 36 30  
    Other 4 13  
Cytogenetic risk (AMLSG), no. patients   .81 
    Standard 24 28  
    High 13 13  
Remission, no. patients   .5 
    CR 26 24  
    No CR 14 19  
EFS, median d 36 37.5 .09 
OS, median d 238 400 .22 
ICEA-ICEP
n 40 43 NA 
Age, mean y (range) 67.9 (60.2-84.5) 67.6 (60.6-76.8) .78 
Sex, no. M/F 24/16 21/22 .38 
Leukocytes, no. patients (mean ×106/mL) 39 (33.9) 41 (50.1) .12 
LDH, no. patients (mean U/L) 39 (620) 39 (564) .66 
Type of AML, no. patients   .03 
    De novo 36 30  
    Other 4 13  
Cytogenetic risk (AMLSG), no. patients   .81 
    Standard 24 28  
    High 13 13  
Remission, no. patients   .5 
    CR 26 24  
    No CR 14 19  
EFS, median d 36 37.5 .09 
OS, median d 238 400 .22 

NA indicates not applicable.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal